{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Nektar Therapeutics"},"Symbol":{"label":"Symbol","value":"NKTR"},"Address":{"label":"Address","value":"455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, California, 94158, United States"},"Phone":{"label":"Phone","value":"+1 415 482-5300"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama, and Hyderabad, India."},"CompanyUrl":{"label":"Company Url","value":"https://www.nektar.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Howard W. Robin","title":"President, Chief Executive Officer & Director"},{"name":"Jonathan Zalevsky","title":"Chief Research & Development Officer"},{"name":"Mary A. Tagliaferri","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}